木犀草素对人肺癌细胞株H460增殖和迁移的影响

储娜; 张璇; 阮大鹏; 陈思远; 王允

doi:10.16766/j.cnki.issn.1674-4152.001904

木犀草素对人肺癌细胞株H460增殖和迁移的影响

doi: 10.16766/j.cnki.issn.1674-4152.001904

蚌埠医学院公共卫生学院，安徽蚌埠 233000

基金项目:

安徽省高校自然科学研究项目 KJ2019A0316

蚌埠医学院研究生科研创新项目 Byycx1907

蚌埠医学院研究生科研创新项目 Byycx20051

详细信息

通讯作者:
王允，E-mail：wy_sunnyday@126.com

中图分类号: R734.2 R730.43
计量
- 文章访问数: 216
- HTML全文浏览量: 93
- PDF下载量: 3
- 被引次数: 0
出版历程
- 收稿日期: 2020-11-26
- 网络出版日期: 2022-02-16

Effect of luteolin on proliferation and migration of human lung cancer cell line H460

School of Public Health, Bengbu Medical College, Bengbu, Anhui 233000, China

摘要

摘要: 目的探讨木犀草素(luteolin，LUT)对人肺大细胞癌H460细胞增殖和迁移能力的影响，并初步分析其作用机制。方法不同浓度的LUT处理H460细胞24 h或48 h后，用MTT法检测细胞活性；用平板克隆形成实验和划痕实验分别检测其克隆形成能力和迁移能力；用蛋白免疫印迹法检测上皮性钙粘附素(E-cadherin)和神经性钙粘附素(N-cadherin)蛋白的表达水平。结果 LUT可呈浓度和时间依赖性抑制H460细胞的活性(P＜0.05)。0、10和20 μmol/L LUT处理H460细胞48 h后，Control、LUT10和LUT20处理组的克隆形成率分别为(1.00±0.05)%、(0.78±0.05)%和(0.49±0.04)%，划痕愈合度分别为(30.37±2.92)%、(26.23±2.42)%和(22.16±1.74)%，N-cadherin和E-cadherin蛋白的表达水平分别为0.62±0.01、0.61±0.01、0.59±0.01，0.85±0.05、0.88±0.05、0.94±0.05。即与Control组相比，LUT10和LUT20处理组的平板克隆形成率和划痕愈合度均下降(均P＜0.05)，E-cadherin蛋白表达水平上调(均P＜0.05)，N-cadherin蛋白表达水平下调(均P＜0.05)。结论 LUT可有效抑制H460细胞的增殖和迁移，这可能与其对E-cadherin和N-cadherin等上皮间质转化相关标志蛋白的调控有关。
- 木犀草素 /
- H460细胞 /
- 上皮间质转化 /
- 化学预防
Abstract: Objective To explore the effect of luteolin (LUT) on the proliferation and migration of human lung large cell carcinoma H460 cells and analyse its mechanism of action. Methods After the H460 cells were treated with different concentrations of LUT for 24 h or 48 h, the cell viability was detected by MTT assay. The clone formation ability and migration ability were detected by plate clone formation test and scratch test, respectively. The expression levels of E-cadherin and N-cadherin protein were detected by Western blotting. Results LUT can inhibit the activity of H460 cells in a concentration-dependent and time-dependent manner (P < 0.05). After H460 cells were treated with 0, 10 and 20 μmol/L LUT for 48 h, the clone formation rates of the control, LUT10 and LUT20 groups respectively were 1.00±0.05, 0.78±0.05 and 0.49±0.04, and the scratch healing degree respectively were (30.37 ±2.92)%, (26.23±2.42)% and (22.16 ±1.74)%. The expression levels of N-cadherin and E-cadherin proteins were 0.62±0.01, 0.61±0.01 and 0.59±0.01; 0.85±0.05, 0.88 ±0.05 and 0.94 ±0.05, respectively. Compared with those of the control group, the plate clone formation rate and scratch healing rate of LUT10 and LUT20 groups decreased (all P < 0.05), the expression level of E-cadherin protein was up-regulated (all P < 0.05) and the expression level of N-cadherin protein was down-regulated (all P < 0.05). Conclusion LUT can effectively inhibit the proliferation and migration of H460 cells, which may be related to the regulation of E-cadherin and N-cadherin-related marker proteins of epithelial-mesenchymal transition.
- Luteolin /
- H460 cell line /
- Epithelial to mesenchymal transition /
- Chemoprevention

HTML全文

图 1 LUT对H460细胞活性的影响

注：与0 μmol/L LUT处理组比较, ^aP＜0.05。

下载: 全尺寸图片幻灯片

图 2 LUT对H460细胞克隆形成能力的影响

注：与对照组比较, ^aP＜0.05。

下载: 全尺寸图片幻灯片

图 3 LUT对H460细胞迁移能力的影响

注：与对照组比较, ^aP＜0.05。

下载: 全尺寸图片幻灯片

图 4 LUT对H460细胞相关蛋白表达的影响

注：与对照组比较, ^aP＜0.05。

下载: 全尺寸图片幻灯片

参考文献(23)

[1]	SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2020[J]. CA: a cancer journal for clinicians, 2020, 70(1): 7-30. doi: 10.3322/caac.21590
[2]	KASAPOGLU U S, ARINC S, GUNGOR S, et al. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions[J]. Clin Respir J, 2016, 10(6): 791-799. doi: 10.1111/crj.12292
[3]	张双美, 王斌, 陈怡, 等. 长链非编码RNA PVT1对非小细胞肺癌细胞增殖和迁移能力的影响及其机制研究[J]. 中华全科医学, 2019, 17(6): 897-901. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201906004.htm
[4]	姜泽群, 李沐涵, 马艳霞, 等. 木犀草素通过上调microRNA-34a-5p诱导肺癌细胞株H460凋亡的研究[J]. 天然产物研究与开发, 2018, 30(2): 169-175, 324. https://www.cnki.com.cn/Article/CJFDTOTAL-TRCW201802001.htm
[5]	SHANMUGAM M K, LEE J H, CHAI E Z, et al. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds[J]. Semin Cancer Biol, 2016, 40-41: 35-47. doi: 10.1016/j.semcancer.2016.03.005
[6]	WALCZAK K, MARCINIAK S, RAJTAR G. Cancer chemoprevention-selected molecular mechanisms[J]. Postepy Hig Med Dosw (Online), 2017, 71: 149-161. http://journals.indexcopernicus.com/fulltxt.php?ICID=1232522
[7]	IMRAN M, RAUF A, ABU-IZNEID T, et al. Luteolin, a flavonoid, as an anticancer agent: A review[J]. Biomed Pharmacother, 2019, 112: 108612. doi: 10.1016/j.biopha.2019.108612
[8]	IIDA K, NAIKI T, NAIKI-ITO A, et al. Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway[J]. Cancer Sci, 2020, 111(4): 1165-1179. doi: 10.1111/cas.14334
[9]	DIA V P, PANGLOLI P. Epithelial-to-mesenchymal transition in paclitaxel-resistant ovarian cancer cells is downregulated by Luteolin[J]. J Cell Physiol, 2017, 232(2): 391-401. doi: 10.1002/jcp.25436
[10]	ZHOU L, WU F, JIN W, et al. Theabrownin inhibits cell cycle progression and tumor growth of lung carcinoma through c-myc-related mechanism[J]. Front Pharmacol, 2017, 8: 75. http://www.onacademic.com/detail/journal_1000040532765210_2f1e.html
[11]	王允, 张玉媛, 陈雪, 等. 联合应用肌醇和木樨草素可选择性抑制肺腺癌A549细胞的生长[J]. 南方医科大学学报, 2018, 38(11): 1378-1383. https://www.cnki.com.cn/Article/CJFDTOTAL-DYJD201811018.htm
[12]	XU D, LI J, LI RY, et al. PD-L1 expression is regulated by NF-κB during EMT signaling in gastric carcinoma[J]. Onco Targets Ther, 2019, 12: 10099-10105. doi: 10.2147/OTT.S224053
[13]	TUORKEY M J. Molecular targets of luteolin in cancer[J]. Eur J Cancer Prev, 2016, 25(1): 65-76. doi: 10.1097/CEJ.0000000000000128
[14]	DENG L, JIANG L, LIN X, et al. Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells[J]. Oncol Lett, 2017, 13(3): 1370-1378. doi: 10.3892/ol.2017.5597
[15]	HAN K, LANG T, ZHANG Z, et al. Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics[J]. Sci Rep, 2018, 8(1): 8537. doi: 10.1038/s41598-018-26761-2
[16]	CUI Q, REN J, ZHOU Q, et al. Effect of asiatic acid on epithelial-mesenchymal transition of human alveolar epithelium A549 cells induced by TGF-beta1[J]. Oncol Lett, 2019, 17(5): 4285-4292.
[17]	WU Z H, LIN C, LIU C C, et al. MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway[J]. Biochem Biophys Res Commun, 2018, 501(4): 1068-1073. doi: 10.1016/j.bbrc.2018.05.109
[18]	GEORGAKOPOULOS-SOARES I, CHARTOUMPEKIS D V, KYRIAZOPOULOU V, et al. EMT factors and metabolic pathways in cancer[J]. Front Oncol, 2020, 10: 499. doi: 10.3389/fonc.2020.00499
[19]	AIELLO N M, MADDIPATI R, NORGARD R J, et al. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration[J]. Dev Cell, 2018, 45(6): 681-695. doi: 10.1016/j.devcel.2018.05.027
[20]	CHA B K, KIM Y S, HWANG K E, et al. Celecoxib and sulindac inhibit TGF-beta1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1[J]. Oncotarget, 2016, 7(35): 57213-57227. doi: 10.18632/oncotarget.11127
[21]	FENG H, LU J J, WANG Y, et al. Osthole inhibited TGF beta-induced epithelial-mesenchymal transition (EMT) by suppressing NF-kappaB mediated Snail activation in lung cancer A549 cells[J]. Cell Adh Migr, 2017, 11(5-6): 464-475. doi: 10.1080/19336918.2016.1259058
[22]	CUI Q, REN J, ZHOU Q, et al. Effect of asiatic acid on epithelial-mesenchymal transition of human alveolar epithelium A549 cells induced by TGF-beta1[J]. Oncol Lett, 2019, 17(5): 4285-4292. http://www.ingentaconnect.com/content/sp/ol/2019/00000017/00000005/art00030
[23]	BREUNIG C, ERDEM N, BOTT A, et al. TGFbeta1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer[J]. Mol Oncol, 2018, 12(9): 1447-1463. doi: 10.1002/1878-0261.12355